Hence, the aim of the present study was to assess the role of bilirubin, and the HMOX1 and UGT1A1 promoter gene variants, which are involved in bilirubin homeostasis, in the NAFLD development in adult patients. This evidence concerns the gene UGT1A1 and metabolic dysfunction-associated steatotic liver disease.